Court revokes license of “Quramax Medical” LLC

Tashkent Inter-District Economic Court issued a decision to revoke the license No. P6580 dated December 10, 2019, issued to “Quramax Medical” LLC for the implementation of pharmaceutical activities.

According to the decision announced at the open court session held today, January 13, it was decided to remove and destroy the unusable drugs.

“Quramax” is the importer and distributor of Doc-1 Max syrup, which is said to have killed at least 20 children in Uzbekistan, as well as Ambronol syrup. The Ministry of Health has identified the substances ethylene glycol and diethylene glycol in the composition of these drugs.

After the tragedies, the Ministry of Health banned the sale of all drugs imported by “Quramax”, and the Pharmaceutical Agency under the Ministry filed a lawsuit to cancel the company’s license. The court decision enters into legal force 10 days after its adoption, unless an appeal (protest) is filed.

“Furthermore, it was decided to issue a private decision on the violation of legal requirements regarding the behavior or inaction of the authorized office and officials related to this economic case, and send it to the Tashkent city prosecutor’s office. An appeal (protest) can be filed against this decision in the prescribed manner,” the Supreme Court said.

It should be recalled that two officials of “Quramax Medical” LLC, as well as two officials of the Scientific Center for Standardization of Medicines were arrested as suspects in the criminal case.

Recently, the Indian regulator suspended the licenses of the pharmaceutical company Marion Biotech, the manufacturer of these drugs. On January 11, the World Health Organization issued an international warning regarding the Doc-1 Max and Ambronol drugs.